|
000
| 02260nam 2200397zi 4500 |
|---|
| 001 | 9.933607 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20240326093326 |
|---|
| 006 | m o d f |
|---|
| 007 | cr cn||||||||| |
|---|
| 008 | 240207t20242024onco ob f000 0 eng d |
|---|
| 020 | |a9780660701004 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aHP40-351/2022E-PDF |
|---|
| 245 | 00|aCanadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) : |b2022 executive summary : key and integrated findings. |
|---|
| 264 | 1|aOttawa, ON : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |c2024. |
|---|
| 264 | 4|c©2024 |
|---|
| 300 | |a1 online resource (9 pages) : |bphotographs |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aCover title. |
|---|
| 500 | |a"Publication date: March 2024." |
|---|
| 500 | |aIssued also in French under title: Programme intégré canadien de surveillance de la résistance aux antimicrobiens (PICRA) : sommaire de 2022 : faits saillants et résultats intégrés. |
|---|
| 504 | |aIncludes bibliographical references. |
|---|
| 520 | |a"The Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) monitors trends in antimicrobial use (AMU) and antimicrobial resistance (AMR) in select foodborne bacterial species from people, animal, and food sources across Canada"--Page 3. |
|---|
| 610 | 20|aCanadian Integrated Program for Antimicrobial Resistance Surveillance. |
|---|
| 650 | 0|aDrug resistance in microorganisms|zCanada. |
|---|
| 650 | 0|aAnti-infective agents|zCanada. |
|---|
| 710 | 2 |aPublic Health Agency of Canada, |eissuing body. |
|---|
| 775 | 08|tProgramme intégré canadien de surveillance de la résistance aux antimicrobiens (PICRA) : |w(CaOODSP)9.933608 |
|---|
| 795 | |tCanadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) 2020 : |w9.917447 |
|---|
| 856 | 40|qPDF|s244 KB|uhttps://publications.gc.ca/collections/collection_2024/aspc-phac/HP40-351-2022-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/services/publications/drugs-health-products/canadian-integrated-program-antimicrobial-resistance-surveillance-2022-executive-summary.html |
|---|